Reducing Antacid Use in a Level IV NICU: A QI Project to Reduce Morbidity. Issue 3 (May 2020)

• Record Type: Journal Article
• Authors: Reinhart, Richelle M.; McClary, Jacquelyn D.; Zhang, Mengqi; Marasch, Jaime L.; Hibbs, Anna Maria; Nock, Mary L.
• Is Part Of: Pediatric quality & safety. Volume 5:Issue 3(2020)
• Publication Date: 2020-05
• Subjects: Pediatric nursing -- Periodicals; Pediatrics -- Periodicals; Patients -- Safety measures -- Periodicals; Children -- Hospital care -- Periodicals; 618.92
• DOI: 10.1097/pq9.0000000000000303
• Languages: English
• ISSNs: 2472-0054

Abstract

Abstract : Introduction: Gastroesophageal reflux is a physiologic occurrence in infants. Clinicians caring for neonates use histamine-2 receptor antagonists (H2As) or proton pump inhibitors (PPIs) for symptomatic reflux, apnea/bradycardia/desaturations, or irritability. Recent studies have shown that there is an increased incidence of infection, fracture, and mortality in neonates who receive antacids. Methods: A multidisciplinary team aimed to decrease nonindicated antacid use in the NICU by 50% by April 2019. Outcome measures include the median number of inappropriate antacid prescriptions and patient-days on acid-suppressants. Interventions include education regarding use and risks of antacids, development of a list of indications deemed "appropriate" for starting an H2A or PPI, mandatory discussion on rounds when considering antacids, documentation of treatment goal, and indication, and an automatic drop-off in the electronic medical record. Results: Baseline data (June–December 2017) showed 19 prescriptions of H2As or PPIs. Of those, 10 orders were deemed "inappropriate, " according to our indicated uses. There were 407 total patient-days of medication-use (median: 51 patient-days). After the implementation of the interventions (October 2018–May 2019), there were 11 prescriptions of antacid medications, 3 of which were deemed "inappropriate." There were 206 total days of medication-use (median: 18.5 patient-days). Conclusions: A multidisciplinary agreement on indications for antacid use in neonates stimulates discussion and creates more purposeful use. Overall, we successfully decreased nonindicated antacid prescriptions in the NICU. For the next steps, we hope to educate physicians on the risks of antacid use and reduce prescriptions in other areas of the hospital and the outpatient setting.